Patent · US Active

Functionalised benzopyran compounds and use thereof

US10370349B2 · kind B2 · utility

0Cited by

31References

8Claims

0Family size

Assignee

Kazia Therapeutics Limited · AU

Inventors

Andrew Heaton · Chepstow, GB
David Brown · Merrick, US
Graham Kelly · Forbes, AU

Key dates

Filing date	Jun 5, 2017
Grant date	Aug 6, 2019
Priority date	—
Expiry date	Jun 5, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D407/10
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Benzopyran compounds, the preparation thereof, and their use in methods for treating cancer and reducing the incidence or risk of cancer recurrence. The cancer can be one or more of pancreatic cancer, colorectal cancer, melanoma, prostate cancer, brain cancer (including paediatric and adult), ovarian cancer, breast cancer, lung cancer, liver cancer, uterine cancer, neuroblastoma, mesothelioma, malignant ascites or peritoneal cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.